X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3333) 3333
Publication (242) 242
Book Review (89) 89
Magazine Article (42) 42
Book Chapter (20) 20
Conference Proceeding (10) 10
Book / eBook (9) 9
Reference (4) 4
Web Resource (4) 4
Paper (1) 1
Presentation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2613) 2613
anti-obesity agents - therapeutic use (2568) 2568
obesity - drug therapy (1866) 1866
obesity (1702) 1702
index medicus (1697) 1697
animals (1220) 1220
male (1186) 1186
anti-obesity agents - pharmacology (970) 970
female (879) 879
pharmacology & pharmacy (710) 710
weight loss (680) 680
adult (637) 637
anti-obesity agents - adverse effects (618) 618
mice (563) 563
lactones - therapeutic use (550) 550
endocrinology & metabolism (535) 535
obesity - metabolism (514) 514
middle aged (486) 486
weight loss - drug effects (460) 460
obesity - therapy (455) 455
weight-loss (448) 448
treatment outcome (430) 430
body mass index (415) 415
orlistat (415) 415
nutrition & dietetics (405) 405
obesity - complications (400) 400
rats (362) 362
anti-obesity agents - administration & dosage (342) 342
obesity - physiopathology (338) 338
risk factors (323) 323
obesity - prevention & control (311) 311
hypoglycemic agents - therapeutic use (309) 309
body weight - drug effects (304) 304
body weight (302) 302
diabetes (285) 285
diet (284) 284
overweight (281) 281
drug therapy (280) 280
insulin-resistance (276) 276
insulin resistance (264) 264
medicine, general & internal (257) 257
mice, inbred c57bl (257) 257
double-blind (246) 246
research (244) 244
life style (243) 243
exercise (241) 241
health aspects (237) 237
sibutramine (235) 235
weight control (235) 235
appetite depressants - therapeutic use (234) 234
chemistry, medicinal (234) 234
double-blind method (232) 232
adolescent (231) 231
care and treatment (229) 229
anti-obesity agents - chemistry (226) 226
bariatric surgery (223) 223
body-weight (222) 222
cyclobutanes - therapeutic use (220) 220
diet, reducing (220) 220
analysis (212) 212
metabolic syndrome (210) 210
obesity - diet therapy (208) 208
obesity - blood (203) 203
obesity - epidemiology (202) 202
food-intake (200) 200
obesity - etiology (197) 197
diabetes mellitus, type 2 - drug therapy (196) 196
physiological aspects (194) 194
dietary supplements (192) 192
aged (190) 190
metabolism (189) 189
biochemistry & molecular biology (188) 188
placebo-controlled trial (187) 187
plant extracts - pharmacology (186) 186
weight reducing preparations (180) 180
adipose-tissue (175) 175
plant extracts - therapeutic use (174) 174
randomized controlled trials as topic (173) 173
glucose (163) 163
prevention (161) 161
randomized controlled-trial (161) 161
fructose - analogs & derivatives (160) 160
leptin (159) 159
dose-response relationship, drug (158) 158
type 2 diabetes (157) 157
anti-obesity (155) 155
energy metabolism - drug effects (153) 153
diet, high-fat - adverse effects (151) 151
phytotherapy (149) 149
drugs (148) 148
lactones - adverse effects (147) 147
weight gain - drug effects (147) 147
insulin (146) 146
clinical trials as topic (145) 145
internal medicine (145) 145
body-mass index (144) 144
disease models, animal (143) 143
abridged index medicus (142) 142
pharmacotherapy (142) 142
adipocytes - drug effects (141) 141
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3204) 3204
German (49) 49
French (33) 33
Spanish (32) 32
Hungarian (11) 11
Danish (10) 10
Japanese (10) 10
Russian (10) 10
Swedish (8) 8
Czech (7) 7
Italian (7) 7
Polish (4) 4
Portuguese (4) 4
Chinese (3) 3
Finnish (3) 3
Croatian (2) 2
Dutch (2) 2
Norwegian (2) 2
Serbian (2) 2
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 04/2016, Volume 12, Issue 4, pp. 423 - 431
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 7, pp. 1765 - 1779
Journal Article
Journal Article
Obesity, ISSN 1930-7381, 05/2013, Volume 21, Issue 5, pp. 935 - 943
Objective: To examine the effects of naltrexone/bupropion (NB) combination therapy on weight and weight‐related risk factors in overweight and obese... 
NUTRITION & DIETETICS | METAANALYSIS | OVERWEIGHT | ENDOCRINOLOGY & METABOLISM | ADULTS | HYPERTENSION | BLOOD-PRESSURE | LIFE | Naltrexone - therapeutic use | Dopamine Uptake Inhibitors - adverse effects | Dyslipidemias - complications | Obesity - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Dopamine Uptake Inhibitors - therapeutic use | Anti-Obesity Agents - adverse effects | Male | Weight Loss - drug effects | Anti-Obesity Agents - therapeutic use | Overweight | Naltrexone - pharmacology | Adult | Female | Drug Therapy, Combination | Bupropion - adverse effects | Bupropion - therapeutic use | Cardiovascular Diseases - etiology | Dopamine Uptake Inhibitors - pharmacology | Double-Blind Method | Obesity - complications | Risk Factors | Narcotic Antagonists - adverse effects | Feeding Behavior - drug effects | Nausea - etiology | Narcotic Antagonists - therapeutic use | Narcotic Antagonists - pharmacology | Obesity - prevention & control | Hypertension - complications | Quality of Life | Bupropion - pharmacology | Naltrexone - adverse effects | Anti-Obesity Agents - pharmacology | Delayed-Action Preparations | Hypertension | Studies | Obesity | Medical research | Nutrition research | Weight control | Behavior | Diabetes | Drug dosages | Food | Quality of life | Clinical Trials | Behavior, Pharmacotherapy, Devices, Surgery
Journal Article
Mini-Reviews in Medicinal Chemistry, ISSN 1389-5575, 2013, Volume 13, Issue 2, pp. 163 - 193
Objective: Piper has been used for long timelike condiment and food, but also in traditional medicine around of the world. This work resumes the available and... 
Pharmacological actions | Piperaceae | Complementary medicine | Phytochemical constituents | Piper | OXIDATIVE STRESS | CHEMISTRY, MEDICINAL | LIPID-PEROXIDATION | ALZHEIMERS-DISEASE | LARVICIDAL ACTIVITY | LUNG CARCINOGENESIS | ORAL SUPPLEMENTATION | B16F-10 MELANOMA-CELLS | IN-VITRO | pharmacological actions | complementary medicine | HEALTHY-VOLUNTEERS | phytochemical constituents | CYTOTOXIC PYRIDONE ALKALOIDS | Anti-Infective Agents - toxicity | Central Nervous System Agents - therapeutic use | Plant Extracts - chemistry | Plant Extracts - toxicity | Antioxidants - chemistry | Obesity - drug therapy | Plant Extracts - pharmacology | Anti-Infective Agents - pharmacology | Cardiovascular Diseases - drug therapy | Humans | Platelet Aggregation Inhibitors - toxicity | Anti-Obesity Agents - therapeutic use | Anti-Obesity Agents - toxicity | Anti-Infective Agents - chemistry | Anti-Inflammatory Agents - therapeutic use | Platelet Aggregation Inhibitors - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Alkaloids - toxicity | Alkaloids - pharmacology | Central Nervous System Agents - chemistry | Anti-Inflammatory Agents - pharmacology | Anti-Inflammatory Agents - toxicity | Anti-Infective Agents - therapeutic use | Antineoplastic Agents, Phytogenic - chemistry | Cardiovascular Agents - toxicity | Antioxidants - pharmacology | Cognition Disorders - drug therapy | Piper - chemistry | Cardiovascular Agents - pharmacology | Neoplasms - drug therapy | Antineoplastic Agents, Phytogenic - toxicity | Antioxidants - toxicity | Cardiovascular Agents - therapeutic use | Anti-Obesity Agents - chemistry | Antioxidants - therapeutic use | Animals | Anti-Inflammatory Agents - chemistry | Central Nervous System Agents - pharmacology | Platelet Aggregation Inhibitors - chemistry | Alkaloids - therapeutic use | Antineoplastic Agents, Phytogenic - pharmacology | Anti-Obesity Agents - pharmacology | Plant Extracts - therapeutic use | Alkaloids - chemistry | Central Nervous System Agents - toxicity | Cardiovascular Agents - chemistry
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 11/2014, Volume 34, Issue 11, pp. 1174 - 1186
More than 26 million people in the United States have type 2 diabetes mellitus (T2D). Many treatment options exist, but achieving long‐term glycemic control in... 
GLP‐1 receptor agonist | type 2 diabetes | GLP-1 receptor agonist | ONCE-DAILY LIXISENATIDE | WEIGHT-LOSS | OPEN-LABEL | BETA-CELL FUNCTION | 52-WEEK EFFICACY | GLUCAGON-LIKE PEPTIDE-1 | BASAL INSULIN | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY |